All Stories

  1. Evaluating a longitudinal mediation model of perceived stress, depressive symptoms, and substance use treatment outcomes.
  2. Buprenorphine treatment for opioid use disorder: recent progress
  3. Randomized pilot trial of Web-based cognitive-behavioral therapy adapted for use in office-based buprenorphine maintenance
  4. Web-based treatment for addiction-CBT4CBT
  5. Cognitive behavioral interventions for alcohol and drug use disorders: Through the stage model and back again.
  6. Training in vain?
  7. Integrated cognitive behavioral therapy for cannabis use and anxiety disorders: Rationale and development
  8. Technology-based interventions for the treatment and recovery management of substance use disorders: A JSAT special issue
  9. A preliminary investigation of Stroop-related intrinsic connectivity in cocaine dependence: associations with treatment outcomes
  10. New Developments in Behavioral Treatments for Substance Use Disorders
  11. An exploratory randomized controlled trial of a novel high-school-based smoking cessation intervention for adolescent smokers using abstinence–contingent incentives and cognitive behavioral therapy
  12. Gender differences in a clinical trial for prescription opioid dependence
  13. Marijuana use is associated with risky sexual behaviors in treatment-seeking polysubstance abusers
  14. Treatment Integrity and Dissemination: Rethinking Fidelity via the Stage Model
  15. Cognitive Behavioral Therapies
  16. Cognitive enhancement as a treatment for drug addictions
  17. Contingency management is efficacious in opioid-dependent outpatients not maintained on agonist pharmacotherapy.
  18. Correspondence of motivational interviewing adherence and competence ratings in real and role-played client sessions.
  19. Functional brain networks associated with cognitive control, cocaine dependence, and treatment outcome.
  20. Psychometric properties of a Spanish-language version of the Short Inventory of Problems.
  21. Smokers versus snorters: Do treatment outcomes differ according to route of cocaine administration?
  22. The Short Inventory of Problems – Revised (SIP-R): Psychometric properties within a large, diverse sample of substance use disorder treatment seekers.
  23. Moderating effects of race in clinical trial participation and outcomes among marijuana-dependent young adults
  24. Efficacy of disulfiram and Twelve Step Facilitation in cocaine-dependent individuals maintained on methadone: A randomized placebo-controlled trial
  25. Motivational enhancement therapy coupled with cognitive behavioral therapy versus brief advice: a randomized trial for treatment of hazardous substance use in pregnancy and after delivery
  26. Combining cognitive behavioral therapy and contingency management to enhance their effects in treating cannabis dependence: less can be more, more or less
  27. A preliminary study of the neural effects of behavioral therapy for substance use disorders
  28. Clinical correlates of co-occurring cannabis and tobacco use: a systematic review
  29. Design and methodological considerations of an effectiveness trial of a computer-assisted intervention: An example from the NIDA Clinical Trials Network
  30. Dissemination of evidence-based practices: how far we've come, and how much further we've got to go
  31. Differences in Treatment Outcome among Marijuana-Dependent Young Adults with and without Antisocial Personality Disorder
  32. A randomized trial adapting contingency management targets based on initial abstinence status of cocaine-dependent patients.
  33. Mindfulness training for smoking cessation: Results from a randomized controlled trial
  34. Primary outcomes in two randomized controlled trials of treatments for cannabis use disorders
  35. An Initial Study of Neural Responses to Monetary Incentives as Related to Treatment Outcome in Cocaine Dependence
  36. Ten Take Home Lessons from the First 10 Years of the CTN and 10 Recommendations for the Future
  37. Treatment outcomes of a stage 1 cognitive-behavioral trial to reduce alcohol use among human immunodeficiency virus-infected out-patients in western Kenya
  38. Computerized versus clinician- versus standard treatment for addiction
  39. Primary outcome indices in illicit drug dependence treatment research: systematic approach to selection and measurement of drug use end-points in clinical trials
  40. Cost and cost-effectiveness of three strategies for training clinicians in motivational interviewing
  41. Bruce Rounsaville (1949-2011)
  42. A criterion-based stepwise approach for training counselors in motivational interviewing
  43. Mutual influence in therapist competence and adherence to motivational enhancement therapy
  44. White matter integrity and behavioral activation in healthy subjects
  45. Editorial [Hot Topic: Pharmacological Treatments of Alcohol and Drug Addiction: Whats New? (Executive Guest Editor: Laurent Karila)]
  46. Effects of Galantamine on Cocaine Use in Chronic Cocaine Users
  47. Neuroscience of Behavioral and Pharmacological Treatments for Addictions
  48. Randomized, double blind, placebo-controlled trial of disulfiram for the treatment of cocaine dependence in methadone-stabilized patients
  49. Galantamine improves sustained attention in chronic cocaine users.
  50. Cognitive Function and Treatment Response in a Randomized Clinical Trial of Computer-Based Training in Cognitive-Behavioral Therapy
  51. Informal discussions in substance abuse treatment sessions with Spanish-speaking clients
  52. Relationship of cognitive function and the acquisition of coping skills in computer assisted treatment for substance use disorders
  53. Community Program Therapist Adherence and Competence in a Motivational Interviewing Assessment Intake Session
  54. Teaching community program clinicians motivational interviewing using expert and train-the-trainer strategies
  55. Quality versus quantity: acquisition of coping skills following computerized cognitive-behavioral therapy for substance use disorders
  56. Treatment process, alliance and outcome in brief versus extended treatments for marijuana dependence
  57. Computer-assisted Therapy in Psychiatry: Be Brave—It’s a New World
  58. Cost-effectiveness of computer-assisted training in cognitive-behavioral therapy as an adjunct to standard care for addiction
  59. Effect of anxiety on treatment presentation and outcome: Results from the Marijuana Treatment Project
  60. Increased error-related thalamic activity during early compared to late cocaine abstinence
  61. Multisite effectiveness trials of treatments for substance abuse and co-occurring problems: Have we chosen the best designs?
  62. White Matter Integrity is Associated with Treatment Outcome Measures in Cocaine Dependence
  63. No Train, No Gain?
  64. Cognitive function as an emerging treatment target for marijuana addiction.
  65. Coping strategy use following computerized cognitive-behavioral therapy for substance use disorders.
  66. Do therapist cultural characteristics influence the outcome of substance abuse treatment for Spanish-speaking adults?
  67. PERHAPS IT IS THE DODO BIRD VERDICT THAT SHOULD BE EXTINCT
  68. Systematic Cultural Adaptation of Cognitive-Behavioral Therapy to Reduce Alcohol Use Among HIV-Infected Outpatients in Western Kenya
  69. Mindfulness Training and Stress Reactivity in Substance Abuse: Results from a Randomized, Controlled Stage I Pilot Study
  70. d-Cycloserine attenuates reactivity to smoking cues in nicotine dependent smokers: A pilot investigation
  71. Evaluating motivational enhancement therapy adherence and competence among Spanish-speaking therapists
  72. Informal discussions in substance abuse treatment sessions
  73. A Randomized Controlled Trial of a Money Management-Based Substance Use Intervention
  74. Construct, concurrent and predictive validity of the URICA: Data from two multi-site clinical trials
  75. Correspondence of motivational enhancement treatment integrity ratings among therapists, supervisors, and observers
  76. Enduring effects of a computer-assisted training program for cognitive behavioral therapy: A 6-month follow-up of CBT4CBT
  77. A multisite randomized effectiveness trial of motivational enhancement therapy for Spanish-speaking substance users.
  78. The alliance in motivational enhancement therapy and counseling as usual for substance use problems.
  79. Pretreatment Brain Activation During Stroop Task Is Associated with Outcomes in Cocaine-Dependent Patients
  80. What is usual about “treatment-as-usual”? Data from two multisite effectiveness trials
  81. A Step Forward in Teaching Addiction Counselors How to Supervise Motivational Interviewing Using a Clinical Trials Training Approach
  82. Community program therapist adherence and competence in motivational enhancement therapy
  83. Computer-Assisted Delivery of Cognitive-Behavioral Therapy for Addiction: A Randomized Trial of CBT4CBT
  84. Serious adverse events in randomized psychosocial treatment studies: Safety or arbitrary edicts?
  85. Using The Experience Sampling Method in The Context of Contingency Management for Substance Abuse Treatment
  86. Enhancing brief cognitive-behavioral therapy with motivational enhancement techniques in cocaine users
  87. Differences in treatment outcome between male alcohol dependent offenders of domestic violence with and without positive drug screens
  88. The cost-effectiveness of four treatments for marijuana dependence
  89. A vision of the next generation of behavioral therapies research in the addictions
  90. W(H)ITHER EMPIRICALLY SUPPORTED THERAPIES (ESTS)? REPLY TO COMMENTARIES
  91. Behavioral impulsivity predicts treatment outcome in a smoking cessation program for adolescent smokers
  92. Naltrexone and Disulfiram in Patients With Alcohol Dependence and Current Depression
  93. A Cognitive Behavioral Therapy for Alcohol-Dependent Domestic Violence Offenders: An Integrated Substance Abuse–Domestic Violence Treatment Approach (SADV)
  94. A Perfect Platform: Combining Contingency Management with Medications for Drug Abuse
  95. Combining Cognitive Behavioral Therapy with Contingency Management for Smoking Cessation in Adolescent Smokers: A Preliminary Comparison of Two Different CBT Formats
  96. Contingency Management to Reduce Substance Use in Individuals Who are Homeless with Co-Occurring Psychiatric Disorders
  97. Issues in Designing and Implementing a Spanish-Language Multi-Site Clinical Trial
  98. Site matters: Multisite randomized trial of motivational enhancement therapy in community drug abuse clinics.
  99. A randomized controlled pilot study of motivational interviewing for patients with psychotic and drug use disorders
  100. Naltrexone and Disulfiram in Patients with Alcohol Dependence and Comorbid Post-Traumatic Stress Disorder
  101. Motivational interviewing to improve treatment engagement and outcome in individuals seeking treatment for substance abuse: A multisite effectiveness study
  102. Reasons for dropout from drug abuse treatment: Symptoms, personality, and motivation
  103. Contingency management treatments: Reinforcing abstinence versus adherence with goal-related activities.
  104. The use of contingency management and motivational/skills-building therapy to treat young adults with marijuana dependence.
  105. Behavioral Therapies for Drug Abuse
  106. Temporoparietal Transcranial Magnetic Stimulation for Auditory Hallucinations: Safety, Efficacy and Moderators in a Fifty Patient Sample
  107. Naltrexone and Disulfiram in Patients with Alcohol Dependence and Comorbid Psychiatric Disorders
  108. Only connect?
  109. Methadone Versus Buprenorphine With Contingency Management or Performance Feedback for Cocaine and Opioid Dependence
  110. Coping and self-efficacy in marijuana treatment: Results from the Marijuana Treatment Project.
  111. Practice Makes Progress? Homework Assignments and Outcome in Treatment of Cocaine Dependence.
  112. We Don't Train in Vain: A Dissemination Trial of Three Strategies of Training Clinicians in Cognitive-Behavioral Therapy.
  113. Behavioral therapies for co-occurring substance use and mood disorders
  114. Priority actions to improve the care of persons with co-occurring substance abuse and other mental disorders: A call to action
  115. Choosing a behavioral therapy platform for pharmacotherapy of substance users
  116. Sex differences in cocaine-dependent individuals' response to disulfiram treatment
  117. Psychosis Induced by Smoking Cessation Clinic Administered Anticholinergic Overload
  118. Cost effectiveness of disulfiram
  119. Efficacy of Disulfiram and Cognitive Behavior Therapy in Cocaine-DependentOutpatients
  120. Prize reinforcement contingency management for treating cocaine users: how low can we go, and with whom?
  121. Ethnic Differences in Substance Abuse Treatment Retention, Compliance, and Outcome From Two Clinical Trials
  122. Brief Treatments for Cannabis Dependence: Findings From a Randomized Multisite Trial.
  123. Millon Clinical Multiaxial Inventory-III Subtypes of Opioid Dependence: Validity and Matching to Behavioral Therapies.
  124. Evidence-based practices for substance use disorders
  125. Single versus multiple drug focus in substance abuse clinical trials research
  126. Bridging the Gap: A Hybrid Model to Link Efficacy and Effectiveness Research in Substance Abuse Treatment
  127. Characteristics, beliefs, and practices of community clinicians trained to provide manual-guided therapy for substance abusers
  128. Dual Diagnosis Motivational Interviewing
  129. Tailoring cannabis dependence treatment for a diverse population
  130. The Marijuana Treatment Project: rationale, design and participant characteristics
  131. On beyond urine: clinically useful assesment instruments in the treatment of drug dependence
  132. One Size Cannot Fit All: A Stage Model for Psychotherapy Manual Development
  133. ‘Intention-to-treat’ meets ‘missing data’: implications of alternate strategies for analyzing clinical trials data
  134. MET meets the real world: design issues and clinical strategies in the Clinical Trials Network
  135. Commentary on Dodo Bird Revisited: Why Aren't We Dodos Yet?
  136. Addictionsenior editorial staff declarations of interest
  137. Client Satisfaction with Three Therapies in the Treatment of Alcohol Dependence: Results from Project MATCH
  138. Clinical and translational research: Introduction to the special issue.
  139. Clinical and translational research: Introduction to the special issue.
  140. Contingency management to enhance naltrexone treatment of opioid dependence: A randomized clinical trial of reinforcement magnitude.
  141. Repetitive Male Genital Self-Mutilation: A Case Report and Discussion of Possible Risk Factors
  142. The URICA as a measure of motivation to change among treatment-seeking individuals with concurrent alcohol and cocaine problems.
  143. The URICA as a measure of motivation to change among treatment-seeking individuals with concurrent alcohol and cocaine problems.
  144. Exposure therapy in the treatment of PTSD among cocaine-dependent individuals: description of procedures
  145. Exposure therapy in the treatment of PTSD among cocaine-dependent individuals
  146. Constrained, confounded and confused: why we really know so little about therapists in treatment outcome research
  147. Manual-guided cognitive-behavioral therapy training: A promising method for disseminating empirically supported substance abuse treatments to the practice community.
  148. Manual-guided cognitive-behavioral therapy training: A promising method for disseminating empirically supported substance abuse treatments to the practice community.
  149. One-year follow-up of disulfiram and psychotherapy for cocaine-alcohol users: sustained effects of treatment
  150. Disulfiram versus placebo for cocaine dependence in buprenorphine-maintained subjects: a preliminary trial
  151. A general system for evaluating therapist adherence and competence in psychotherapy research in the addictions
  152. Substance Dependence Posttraumatic Stress Disorder Therapy
  153. Old Psychotherapies for Cocaine Dependence Revisited
  154. ‘Research’ versus ‘real-world’ patients: representativeness of participants in clinical trials of treatments for cocaine dependence
  155. Do patients change in the ways we intend? Assessing acquisition of coping skills among cocaine-dependent patients.
  156. Gender Differences in Treatment-Seeking Cocaine Abusers - Implications for Treatment and Prognosis
  157. Options for Managing Psychotropic Medications in Drug-Abusing Patients Participating in Behavioral Therapies Clinical Trials
  158. A randomized trial of buprenorphine maintenance for heroin dependence in a primary care clinic for substance users versus a methadone clinic
  159. Fluoxetine treatment of depressive disorders in methadone-maintained opioid addicts
  160. Matching patients with alcohol disorders to treatments: Clinical implications from Project MATCH
  161. Internal validity of project MATCH treatments: Discriminability and integrity.
  162. Project MATCH secondary a priori hypotheses
  163. NONPHARMACOLOGIC APPROACHES TO SUBSTANCE ABUSE TREATMENT
  164. Integrating psychotherapy and pharmacotherapy to improve drug abuse outcomes
  165. Contribution of the therapeutic alliance to outcome in active versus control psychotherapies.
  166. Now you see it, now you don't: A comparison of traditional versus random-effects regression models in the analysis of longitudinal follow-up data from a clinical trial.
  167. The therapeutic alliance and its relationship to alcoholism treatment participation and outcome.
  168. Relapse prevention as a psychosocial treatment: A review of controlled clinical trials.
  169. Primary care-based ambulatory opioid detoxification
  170. Fluoxetine Treatment for Dually Diagnosed Methadone Maintained Opioid Addicts:
  171. Connecticut Mental Health Center: Clinical, Research and Training Programs in the Addictions